Author

J. Yuan

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Associations between glucolipid metabolic indices with the risk and progression of cardiovascular-kidney-metabolic syndrome in MASLD: evidence from the UK biobank

The predictive performance of biomarkers reflecting insulin resistance, inflammation, and metabolic dysregulation in individuals with MASLD is compared to identify key determinants of CKM progression and assess the rationale for an expanded Cardiovascular -Kidney-Metabolic-Liver (CKML) paradigm.

R. Wang, F. Tan, J. Yuan et al. · European Heart Journal · 0 citations

Open access Oct 2026

Individual and combined prognostic value of LDL-C, Lp(a), and hsCRP for cardiovascular and cerebrovascular events in post-PCI patients: evidence from two large contemporary cohorts

Substantial residual cardiovascular risk persists in patients with coronary artery disease (CAD) despite contemporary secondary prevention. While combined assessment of low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], and high-sensitivity C-reactive protein (hsCRP) has demonstrated prognostic...

K. Zhang, K. Yan, M. Liu et al. · European Heart Journal · 0 citations

Open access Oct 2026

Glucose-to-potassium ratio independently predicts long-term adverse outcomes in patients with coronary artery disease after PCI

The glucose-to-potassium ratio (GPR) is an emerging metabolic biomarker that has demonstrated prognostic value in several acute conditions, including intracerebral hemorrhage and heart failure. However, its prognostic significance in patients with coronary artery disease (CAD) remains undetermined. This st...

K. Zhang, K. Yan, M. Liu et al. · European Heart Journal · 0 citations